Shionogi & Key Executives
This section highlights Shionogi & 's key executives, including their titles and compensation details.
Find Contacts at Shionogi &
(Showing 0 of )
Shionogi & Earnings
This section highlights Shionogi & 's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Date:
May 12, 2025
Time:
Before Market
Est. EPS:
$-
Status:
Unconfirmed
Last Earnings Results
Date:
January 29, 2025
EPS:
$59.56
Est. EPS:
$43.47
Revenue:
$119.63B
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q3 | 2024 | 2025-01-31 | N/A | N/A |
| Read Transcript | Q2 | 2024 | 2024-10-29 | N/A | N/A |
| Read Transcript | Q1 | 2024 | 2024-07-29 | $130.90 | $108.07 |
| Read Transcript | Q2 | 2023 | 2023-11-01 | N/A | N/A |
| Read Transcript | Q1 | 2023 | 2023-07-31 | $126.02 | $144.62 |
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-117957 for Insomnia; sivopixant for Neuropathic pain, Sleep Apnea Syndrome, and Refractory/unexplainedchronic cough; S-637880 for Neuropathic Low Back Pain; Zuranolone for Depression; SDT-001 for attention-deficit/hyperactivity disorder patients; BPN14770 for Fragile X syndrome and Alzheimer's disease; and S-237648 and S-309309 for Obesity. In addition, the company develops ADR-001 for Decompensated liver cirrhosis; S-723595 for NASH; S-588410 for Esophageal and Bladder cancer; S-488210 for Head and neck squamouscell carcinoma; S-588210 for Solid tumor; S-222611 for Malignant tumor; S-770108 for Idiopathic pulmonary fibrosis; SR-0379 for Cutaneous ulcer; S-005151 for Stroke and Epidermolysis bullosa; S-531011 for Solid tumor; S-0373 for Spinocerebellar ataxia; and S-600918 and S-217622 for COVID-19, as well as S-555739 for Control of the aggravation of COVID-19. Further, it offers antibody test kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with Nagasaki University, the National Institute of Infectious Diseases, and The Kitasato University to develop antimalarial drugs. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.
Healthcare
Drug Manufacturers - Specialty & Generic
$2306.50
Stock Price
$1.96T
Market Cap
-
Employees
Osaka, None
Location
Financial Statements
Access annual & quarterly financial statements for Shionogi & , including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $435.08B | $426.68B | $335.14B | $297.18B | $333.37B |
| Cost of Revenue | $66.00B | $62.25B | $55.41B | $52.52B | $56.78B |
| Gross Profit | $369.09B | $364.44B | $279.72B | $244.65B | $276.59B |
| Gross Profit Ratio | 84.80% | 85.41% | 83.50% | 82.33% | 82.97% |
| Research and Development Expenses | $102.64B | $102.39B | $73.00B | $54.25B | $47.95B |
| General and Administrative Expenses | $81.08B | $97.78B | $91.77B | $91.90B | $95.09B |
| Selling and Marketing Expenses | $13.91B | $7.52B | $9.98B | $13.04B | $15.41B |
| Selling General and Administrative Expenses | $94.99B | $97.78B | $91.77B | $91.90B | $95.09B |
| Other Expenses | $- | $- | $4.64B | $-18.94B | $-1.30B |
| Operating Expenses | $197.63B | $215.43B | $169.41B | $127.21B | $145.96B |
| Cost and Expenses | $263.62B | $277.68B | $224.82B | $179.74B | $202.74B |
| Interest Income | $51.67B | $75.83B | $16.80B | $26.52B | $30.50B |
| Interest Expense | $6.70B | $4.50B | $841.00M | $941.00M | $2.62B |
| Depreciation and Amortization | $18.32B | $17.16B | $16.29B | $14.71B | $14.04B |
| EBITDA | $217.81B | $176.41B | $143.42B | $158.67B | $174.47B |
| EBITDA Ratio | 50.06% | 56.72% | 42.81% | 53.42% | 52.57% |
| Operating Income | $171.46B | $149.00B | $110.31B | $117.44B | $130.63B |
| Operating Income Ratio | 39.41% | 34.92% | 32.92% | 39.52% | 39.18% |
| Total Other Income Expenses Net | $26.82B | $59.78B | $15.96B | $25.58B | $27.89B |
| Income Before Tax | $198.28B | $220.33B | $126.27B | $143.02B | $158.52B |
| Income Before Tax Ratio | 45.57% | 51.64% | 37.68% | 48.13% | 47.55% |
| Income Tax Expense | $37.71B | $35.84B | $12.83B | $30.96B | $36.32B |
| Net Income | $162.03B | $184.97B | $114.19B | $111.86B | $122.19B |
| Net Income Ratio | 37.24% | 43.35% | 34.07% | 37.64% | 36.65% |
| EPS | $186.17 | $206.90 | $126.12 | $121.55 | $131.77 |
| EPS Diluted | $558.32 | $206.82 | $126.08 | $121.51 | $131.63 |
| Weighted Average Shares Outstanding | 870.33M | 893.11M | 904.43M | 919.32M | 926.39M |
| Weighted Average Shares Outstanding Diluted | 290.21M | 893.41M | 904.74M | 919.66M | 927.38M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $119.63B | $116.38B | $97.59B | $98.26B | $106.28B | $121.23B | $109.31B | $88.34B | $187.57B | $78.94B | $71.84B | $115.51B | $74.54B | $76.12B | $68.97B | $72.76B | $75.97B | $77.05B | $71.40B | $79.86B |
| Cost of Revenue | $15.90B | $16.77B | $14.44B | $16.30B | $14.52B | $14.77B | $13.12B | $17.68B | $17.20B | $14.42B | $12.95B | $15.56B | $12.87B | $14.65B | $12.33B | $16.58B | $13.09B | $11.37B | $11.49B | $15.79B |
| Gross Profit | $103.73B | $99.62B | $83.14B | $81.96B | $91.76B | $106.47B | $96.19B | $70.66B | $170.37B | $64.52B | $58.89B | $99.95B | $61.67B | $61.47B | $56.63B | $56.18B | $62.88B | $65.68B | $59.91B | $64.07B |
| Gross Profit Ratio | 86.71% | 85.60% | 85.20% | 83.40% | 86.30% | 87.80% | 88.00% | 80.00% | 90.80% | 81.70% | 82.00% | 86.50% | 82.70% | 80.80% | 82.10% | 77.22% | 82.77% | 85.24% | 83.91% | 80.23% |
| Research and Development Expenses | $22.62B | $27.39B | $29.43B | $30.01B | $25.43B | $22.21B | $25.00B | $27.58B | $26.08B | $26.20B | $22.53B | $24.78B | $20.04B | $13.45B | $14.73B | $15.02B | $14.38B | $12.69B | $12.17B | $47.95B |
| General and Administrative Expenses | $- | $- | $- | $27.99B | $24.14B | $24.32B | $23.19B | $27.09B | $24.17B | $24.07B | $22.45B | $25.23B | $22.29B | $22.50B | $21.75B | $25.67B | $23.07B | $22.29B | $20.87B | $6.06B |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $7.52B | $- | $- | $- | $9.98B | $- | $- | $- | $13.04B | $- | $- | $- | $15.41B |
| Selling General and Administrative Expenses | $25.45B | $23.69B | $24.04B | $27.99B | $24.14B | $24.32B | $23.19B | $27.09B | $24.17B | $24.07B | $22.45B | $25.23B | $22.29B | $22.50B | $21.75B | $25.67B | $23.07B | $22.29B | $20.87B | $21.47B |
| Other Expenses | $2.31B | $- | $1.56B | $- | $- | $- | $- | $- | $- | $- | $1.49B | $55.00M | $1.58B | $1.65B | $1.36B | $260.00M | $-21.47B | $1.01B | $1.26B | $1.42B |
| Operating Expenses | $50.38B | $51.09B | $55.03B | $58.00B | $51.13B | $54.94B | $49.60B | $68.13B | $52.12B | $48.72B | $46.47B | $50.06B | $43.91B | $37.60B | $37.84B | $40.95B | $15.98B | $35.99B | $34.30B | $32.69B |
| Cost and Expenses | $66.28B | $67.85B | $69.48B | $74.30B | $65.64B | $69.71B | $62.72B | $85.81B | $69.32B | $63.14B | $59.41B | $65.62B | $56.78B | $52.25B | $50.17B | $57.52B | $29.07B | $47.36B | $45.78B | $48.48B |
| Interest Income | $- | $12.32B | $11.25B | $21.92B | $11.37B | $10.59B | $10.07B | $22.69B | $13.31B | $12.67B | $27.91B | $1.78B | $6.68B | $4.11B | $4.23B | $10.64B | $3.08B | $7.91B | $4.89B | $28.30B |
| Interest Expense | $- | $2.77B | $2.84B | $2.70B | $3.12B | $2.21B | $954.00M | $3.67B | $747.00M | $808.00M | $24.00M | $186.00M | $485.00M | $87.00M | $82.00M | $- | $330.00M | $477.00M | $447.00M | $2.54B |
| Depreciation and Amortization | $5.44B | $5.37B | $4.92B | $4.88B | $4.57B | $4.49B | $4.38B | $4.21B | $4.30B | $4.34B | $4.30B | $4.32B | $4.18B | $4.10B | $3.75B | $3.79B | $3.74B | $3.62B | $3.63B | $3.65B |
| EBITDA | $58.79B | $65.45B | $33.03B | $34.52B | $45.20B | $56.01B | $50.97B | $29.43B | $122.56B | $20.15B | $16.72B | $54.56B | $21.94B | $27.97B | $22.54B | $-5.58B | $50.63B | $33.31B | $29.25B | $45.25B |
| EBITDA Ratio | 49.14% | 56.24% | 33.85% | 29.35% | 53.22% | 54.94% | 55.84% | 33.32% | 72.43% | 41.58% | 62.13% | 48.47% | 38.39% | 42.14% | 38.82% | 40.77% | 70.70% | 53.50% | 47.81% | 56.66% |
| Operating Income | $53.35B | $48.53B | $28.11B | $23.96B | $40.63B | $51.52B | $46.59B | $2.53B | $118.25B | $15.80B | $12.42B | $49.89B | $17.76B | $23.87B | $18.79B | $15.24B | $46.89B | $29.69B | $25.62B | $31.38B |
| Operating Income Ratio | 44.60% | 41.70% | 28.81% | 24.38% | 38.23% | 42.50% | 42.62% | 2.86% | 63.04% | 20.02% | 17.29% | 43.19% | 23.82% | 31.36% | 27.25% | 20.94% | 61.73% | 38.53% | 35.88% | 39.29% |
| Total Other Income Expenses Net | $8.69B | $8.78B | $8.41B | $9.84B | $8.25B | $8.38B | $9.12B | $19.02B | $11.61B | $14.41B | $27.35B | $2.54B | $5.46B | $3.19B | $3.60B | $10.95B | $25.01B | $7.22B | $3.99B | $7.68B |
| Income Before Tax | $62.04B | $57.31B | $36.52B | $33.80B | $48.88B | $59.90B | $55.70B | $21.55B | $130.81B | $27.67B | $40.31B | $51.48B | $23.95B | $27.89B | $22.94B | $26.19B | $49.64B | $37.12B | $30.06B | $39.06B |
| Income Before Tax Ratio | 51.86% | 49.24% | 37.43% | 34.39% | 46.00% | 49.41% | 50.96% | 24.39% | 69.74% | 35.05% | 56.11% | 44.57% | 32.13% | 36.64% | 33.26% | 35.99% | 65.35% | 48.18% | 42.10% | 48.91% |
| Income Tax Expense | $11.58B | $4.74B | $6.22B | $-340.00M | $12.64B | $11.91B | $13.49B | $-5.18B | $30.44B | $4.69B | $5.88B | $8.78B | $6.24B | $7.07B | $-9.26B | $200.00M | $12.95B | $9.28B | $8.52B | $7.67B |
| Net Income | $50.67B | $52.50B | $30.64B | $34.81B | $36.63B | $48.03B | $42.56B | $27.24B | $100.46B | $22.54B | $34.72B | $43.19B | $17.87B | $20.89B | $32.24B | $25.79B | $36.69B | $27.84B | $21.54B | $31.35B |
| Net Income Ratio | 42.36% | 45.11% | 31.39% | 35.42% | 34.47% | 39.62% | 38.94% | 30.83% | 53.56% | 28.56% | 48.33% | 37.39% | 23.97% | 27.45% | 46.75% | 35.44% | 48.30% | 36.14% | 30.16% | 39.26% |
| EPS | $59.55 | $61.70 | $36.02 | $40.69 | $42.27 | $54.64 | $48.16 | $30.82 | $113.25 | $24.97 | $38.35 | $47.70 | $19.74 | $23.08 | $35.61 | $27.84 | $39.61 | $29.89 | $26.85 | $33.88 |
| EPS Diluted | $59.55 | $61.70 | $36.01 | $40.69 | $42.25 | $54.62 | $48.14 | $30.82 | $113.21 | $24.96 | $38.34 | $47.68 | $19.73 | $23.07 | $35.60 | $27.84 | $39.60 | $29.88 | $26.83 | $33.88 |
| Weighted Average Shares Outstanding | 850.88M | 850.79M | 850.79M | 854.53M | 865.70M | 878.19M | 882.91M | 882.92M | 886.20M | 901.89M | 904.45M | 904.48M | 904.45M | 904.46M | 904.39M | 909.66M | 925.41M | 930.73M | 911.50M | 913.03M |
| Weighted Average Shares Outstanding Diluted | 850.88M | 850.79M | 850.79M | 854.53M | 866.00M | 878.49M | 883.22M | 882.92M | 886.50M | 902.19M | 904.75M | 904.77M | 904.76M | 904.76M | 904.69M | 925.41M | 925.71M | 931.03M | 911.95M | 924.42M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $358.09B | $309.22B | $254.42B | $276.17B | $208.86B |
| Short Term Investments | $- | $254.13B | $210.76B | $142.15B | $171.16B |
| Cash and Short Term Investments | $358.09B | $563.36B | $465.18B | $418.32B | $380.02B |
| Net Receivables | $122.83B | $109.78B | $122.97B | $- | $79.73B |
| Inventory | $64.92B | $57.92B | $45.89B | $38.00B | $33.82B |
| Other Current Assets | $238.37B | $307.27B | $235.93B | $164.09B | $193.62B |
| Total Current Assets | $784.21B | $784.19B | $659.21B | $556.24B | $516.03B |
| Property Plant Equipment Net | $124.03B | $118.57B | $112.42B | $95.71B | $76.01B |
| Goodwill | $15.29B | $9.82B | $9.64B | $9.36B | $10.85B |
| Intangible Assets | $117.62B | $96.31B | $81.22B | $76.56B | $46.54B |
| Goodwill and Intangible Assets | $132.91B | $106.13B | $90.86B | $85.92B | $57.39B |
| Long Term Investments | $320.09B | $280.81B | $275.21B | $249.40B | $219.05B |
| Tax Assets | $13.53B | $22.10B | $12.91B | $11.73B | $3.05B |
| Other Non-Current Assets | $42.16B | $3.00M | $5.00M | $4.00M | $4.00M |
| Total Non-Current Assets | $632.71B | $527.61B | $491.40B | $442.75B | $355.50B |
| Other Assets | $- | $1.00M | $- | $- | $- |
| Total Assets | $1.42T | $1.31T | $1.15T | $998.99B | $871.53B |
| Account Payables | $14.81B | $14.01B | $16.37B | $9.90B | $10.76B |
| Short Term Debt | $2.87B | $3.01B | $2.94B | $3.38B | $6.72B |
| Tax Payables | $20.84B | $42.22B | $17.97B | $28.03B | $21.89B |
| Deferred Revenue | $- | $71.94B | $40.00B | $49.42B | $39.44B |
| Other Current Liabilities | $95.39B | $27.38B | $47.11B | $9.45B | $41.75B |
| Total Current Liabilities | $133.91B | $158.55B | $124.40B | $100.18B | $81.12B |
| Long Term Debt | $8.75B | $6.40B | $3.73B | $4.61B | $4.79B |
| Deferred Revenue Non-Current | $- | $17.71B | $21.03B | $21.56B | $20.27B |
| Deferred Tax Liabilities Non-Current | $4.36B | $5.92B | $7.81B | $7.75B | $373.00M |
| Other Non-Current Liabilities | $17.34B | $1.35B | $356.00M | $345.00M | $21.00B |
| Total Non-Current Liabilities | $30.45B | $31.37B | $32.92B | $34.26B | $25.80B |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $164.36B | $189.92B | $157.32B | $134.44B | $106.92B |
| Preferred Stock | $- | $914.02B | $810.84B | $729.27B | $672.71B |
| Common Stock | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B |
| Retained Earnings | $1.07T | $940.61B | $832.96B | $752.25B | $708.29B |
| Accumulated Other Comprehensive Income Loss | $271.78B | $186.03B | $164.82B | $116.84B | $91.85B |
| Other Total Stockholders Equity | $-123.64B | $-47.87B | $-43.40B | $-44.26B | $-1.49T |
| Total Stockholders Equity | $1.24T | $1.10T | $975.66B | $846.11B | $764.56B |
| Total Equity | $1.25T | $1.12T | $993.28B | $864.55B | $764.61B |
| Total Liabilities and Stockholders Equity | $1.42T | $1.31T | $1.15T | $998.99B | $871.53B |
| Minority Interest | $17.24B | $21.83B | $17.62B | $18.44B | $51.00M |
| Total Liabilities and Total Equity | $1.42T | $1.31T | $1.15T | $998.99B | $871.53B |
| Total Investments | $320.09B | $247.71B | $242.48B | $217.44B | $202.16B |
| Total Debt | $11.62B | $9.41B | $6.67B | $7.99B | $8.15B |
| Net Debt | $-346.47B | $-299.81B | $-247.75B | $-268.19B | $-200.71B |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $305.58B | $303.40B | $281.96B | $358.09B | $284.79B | $252.37B | $289.08B | $309.22B | $218.67B | $198.04B | $204.63B | $254.42B | $201.28B | $236.06B | $206.32B | $276.17B | $204.79B | $240.44B | $170.04B | $208.86B |
| Short Term Investments | $- | $- | $- | $215.76B | $222.99B | $301.07B | $287.31B | $254.13B | $273.40B | $290.52B | $298.18B | $210.76B | $240.76B | $206.79B | $210.01B | $142.15B | $189.92B | $185.88B | $189.64B | $171.16B |
| Cash and Short Term Investments | $305.58B | $303.40B | $281.96B | $358.09B | $507.77B | $553.45B | $576.38B | $563.36B | $492.06B | $488.56B | $502.80B | $465.18B | $442.04B | $442.85B | $416.33B | $418.32B | $394.71B | $426.31B | $359.68B | $380.02B |
| Net Receivables | $144.01B | $131.13B | $122.84B | $122.83B | $154.22B | $153.12B | $115.36B | $109.78B | $164.33B | $99.66B | $97.93B | $122.97B | $80.41B | $79.35B | $75.22B | $- | $83.73B | $79.02B | $74.85B | $79.73B |
| Inventory | $67.94B | $66.12B | $65.47B | $64.92B | $64.14B | $64.16B | $62.60B | $57.92B | $58.69B | $56.07B | $52.06B | $45.89B | $41.75B | $40.32B | $40.70B | $38.00B | $40.90B | $39.07B | $39.79B | $33.82B |
| Other Current Assets | $311.16B | $297.26B | $297.57B | $238.37B | $254.08B | $336.41B | $316.24B | $307.27B | $307.86B | $326.15B | $329.30B | $235.93B | $263.23B | $226.20B | $235.95B | $164.09B | $214.71B | $203.85B | $211.85B | $193.62B |
| Total Current Assets | $828.69B | $797.91B | $767.85B | $784.21B | $757.22B | $806.06B | $783.28B | $784.19B | $749.55B | $679.93B | $683.92B | $659.21B | $586.68B | $581.92B | $558.19B | $556.24B | $544.13B | $562.38B | $496.52B | $516.03B |
| Property Plant Equipment Net | $131.04B | $121.07B | $123.08B | $124.03B | $118.75B | $119.05B | $117.55B | $118.57B | $115.98B | $113.53B | $114.77B | $112.42B | $106.36B | $99.17B | $96.10B | $95.71B | $79.02B | $74.90B | $74.50B | $76.01B |
| Goodwill | $15.82B | $15.59B | $15.80B | $15.29B | $26.05B | $26.80B | $9.89B | $9.82B | $10.07B | $10.08B | $9.86B | $9.64B | $9.49B | $9.46B | $9.41B | $9.36B | $25.40B | $27.23B | $27.43B | $10.85B |
| Intangible Assets | $144.68B | $140.66B | $147.02B | $117.62B | $105.90B | $99.83B | $99.90B | $96.31B | $108.21B | $108.49B | $97.12B | $81.22B | $78.37B | $78.23B | $78.55B | $76.56B | $52.25B | $46.95B | $47.92B | $46.54B |
| Goodwill and Intangible Assets | $160.50B | $156.25B | $162.82B | $132.91B | $131.95B | $126.63B | $109.80B | $106.13B | $118.28B | $118.57B | $106.99B | $90.86B | $87.87B | $87.69B | $87.95B | $85.92B | $77.65B | $74.19B | $75.36B | $57.39B |
| Long Term Investments | $- | $324.89B | $340.04B | $320.09B | $45.91B | $-18.92B | $331.98B | $-6.42B | $-37.12B | $-49.78B | $283.34B | $275.21B | $248.11B | $240.87B | $4.43B | $75.29B | $17.40B | $20.69B | $13.99B | $31.00B |
| Tax Assets | $- | $15.43B | $12.02B | $13.53B | $14.15B | $17.54B | $21.18B | $22.10B | $9.66B | $11.26B | $11.93B | $12.91B | $9.88B | $10.79B | $11.76B | $11.73B | $4.82B | $4.02B | $5.23B | $3.05B |
| Other Non-Current Assets | $396.36B | $41.19B | $42.87B | $42.16B | $291.89B | $359.23B | $3.00M | $287.23B | $305.27B | $322.43B | $3.00M | $5.00M | $5.00M | $3.00M | $241.92B | $174.11B | $222.71B | $194.66B | $198.98B | $188.05B |
| Total Non-Current Assets | $687.90B | $658.82B | $680.83B | $632.71B | $602.64B | $603.54B | $580.50B | $527.61B | $512.06B | $516.01B | $517.03B | $491.40B | $452.22B | $438.53B | $442.17B | $442.75B | $401.60B | $368.46B | $368.05B | $355.50B |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $1.00M | $- | $- | $1.00M | $- | $- | $- | $- | $- | $- | $1.00M | $1.00M | $- |
| Total Assets | $1.52T | $1.46T | $1.45T | $1.42T | $1.36T | $1.41T | $1.36T | $1.31T | $1.26T | $1.20T | $1.20T | $1.15T | $1.04T | $1.02T | $1.00T | $998.99B | $945.73B | $930.85B | $864.57B | $871.53B |
| Account Payables | $13.13B | $12.74B | $11.19B | $14.81B | $12.70B | $14.69B | $15.30B | $14.01B | $16.78B | $17.84B | $15.58B | $16.37B | $11.14B | $10.26B | $9.91B | $9.90B | $10.33B | $9.43B | $11.13B | $10.76B |
| Short Term Debt | $3.62B | $- | $3.10B | $2.87B | $3.29B | $3.17B | $3.08B | $3.01B | $2.78B | $2.97B | $2.97B | $2.94B | $3.17B | $3.26B | $3.33B | $3.38B | $3.32B | $3.41B | $3.44B | $3.36B |
| Tax Payables | $- | $- | $14.40B | $20.84B | $13.74B | $29.16B | $17.51B | $42.22B | $31.02B | $17.09B | $12.26B | $17.97B | $5.43B | $18.15B | $11.22B | $28.03B | $21.52B | $24.25B | $15.19B | $21.89B |
| Deferred Revenue | $- | $22.23B | $14.40B | $20.84B | $39.22B | $65.02B | $52.02B | $71.94B | $50.43B | $34.31B | $35.20B | $40.00B | $23.73B | $36.89B | $33.78B | $49.42B | $35.41B | $35.65B | $29.87B | $39.44B |
| Other Current Liabilities | $91.77B | $77.94B | $80.31B | $74.54B | $46.35B | $35.42B | $52.21B | $27.38B | $44.32B | $54.78B | $63.83B | $47.11B | $51.02B | $21.29B | $27.91B | $9.45B | $1.81B | $-654.00M | $11.35B | $5.67B |
| Total Current Liabilities | $108.52B | $112.90B | $123.41B | $133.91B | $115.29B | $147.44B | $140.12B | $158.55B | $145.32B | $127.00B | $129.84B | $124.40B | $94.49B | $89.86B | $86.15B | $100.18B | $72.40B | $72.08B | $70.98B | $81.12B |
| Long Term Debt | $19.43B | $8.36B | $8.92B | $8.75B | $6.56B | $6.27B | $6.47B | $6.40B | $5.88B | $3.85B | $3.67B | $3.73B | $3.91B | $4.17B | $4.42B | $4.61B | $4.10B | $4.32B | $4.59B | $4.79B |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $15.61B | $16.14B | $16.88B | $17.71B | $22.30B | $21.87B | $21.12B | $21.03B | $20.00B | $20.04B | $20.22B | $21.56B | $16.73B | $17.26B | $19.80B | $20.27B |
| Deferred Tax Liabilities Non-Current | $- | $4.19B | $4.54B | $4.36B | $6.18B | $6.46B | $6.29B | $5.92B | $8.25B | $8.88B | $8.46B | $7.81B | $7.87B | $7.15B | $7.31B | $7.75B | $1.90B | $343.00M | $364.00M | $373.00M |
| Other Non-Current Liabilities | $26.03B | $20.46B | $25.41B | $17.33B | $1.89B | $1.84B | $1.84B | $1.35B | $1.34B | $1.34B | $1.36B | $356.00M | $321.00M | $336.00M | $359.00M | $345.00M | $332.00M | $338.00M | $351.00M | $737.00M |
| Total Non-Current Liabilities | $45.46B | $33.02B | $34.33B | $30.45B | $30.23B | $30.72B | $31.48B | $31.37B | $37.77B | $35.94B | $34.61B | $32.92B | $32.10B | $31.69B | $32.30B | $34.26B | $23.06B | $22.25B | $25.11B | $25.80B |
| Other Liabilities | $- | $4.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $153.98B | $145.93B | $157.75B | $164.35B | $145.52B | $178.16B | $171.60B | $189.92B | $183.09B | $162.95B | $164.44B | $157.32B | $126.59B | $121.56B | $118.46B | $134.44B | $95.46B | $94.33B | $96.08B | $106.92B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $934.70B | $- | $- | $- | $827.85B | $810.84B | $769.02B | $767.15B | $- | $- | $- | $- | $- | $- |
| Common Stock | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B |
| Retained Earnings | $1.08T | $1.05T | $1.00T | $1.07T | $1.03T | $1.01T | $961.29B | $940.61B | $937.46B | $853.61B | $849.23B | $832.96B | $790.91B | $789.13B | $768.36B | $752.25B | $728.68B | $707.72B | $682.55B | $708.29B |
| Accumulated Other Comprehensive Income Loss | $296.94B | $270.63B | $304.08B | $271.78B | $236.45B | $245.40B | $235.72B | $186.03B | $170.65B | $182.74B | $186.51B | $164.82B | $125.65B | $113.97B | $117.98B | $116.84B | $96.65B | $94.71B | $89.75B | $91.85B |
| Other Total Stockholders Equity | $-51.62B | $-51.61B | $-55.10B | $-123.65B | $-94.47B | $-67.11B | $-47.87B | $-47.87B | $-74.14B | $-48.06B | $-42.65B | $-43.40B | $-43.17B | $-43.26B | $-43.46B | $-44.26B | $-7.10B | $12.75B | $-25.14B | $-56.86B |
| Total Stockholders Equity | $1.35T | $1.29T | $1.27T | $1.24T | $1.19T | $1.21T | $1.17T | $1.10T | $1.06T | $1.01T | $1.01T | $975.66B | $894.67B | $881.12B | $864.16B | $846.11B | $839.52B | $836.46B | $768.44B | $764.56B |
| Total Equity | $1.36T | $1.31T | $1.29T | $1.25T | $1.21T | $1.23T | $1.19T | $1.12T | $1.08T | $1.03T | $1.04T | $993.28B | $912.31B | $898.89B | $881.89B | $864.55B | $850.27B | $836.51B | $768.49B | $764.61B |
| Total Liabilities and Stockholders Equity | $1.52T | $1.46T | $1.45T | $1.42T | $1.36T | $1.41T | $1.36T | $1.31T | $1.26T | $1.20T | $1.20T | $1.15T | $1.04T | $1.02T | $1.00T | $998.99B | $945.73B | $930.85B | $864.57B | $871.53B |
| Minority Interest | $17.02B | $18.01B | $17.33B | $17.24B | $22.01B | $22.05B | $21.76B | $21.83B | $23.29B | $23.41B | $22.15B | $17.62B | $17.64B | $17.77B | $17.73B | $18.44B | $10.75B | $52.00M | $53.00M | $51.00M |
| Total Liabilities and Total Equity | $1.52T | $1.46T | $1.45T | $1.42T | $1.36T | $1.41T | $1.36T | $1.31T | $1.26T | $1.20T | $1.20T | $1.15T | $1.04T | $1.02T | $1.00T | $998.99B | $945.73B | $930.85B | $864.57B | $871.53B |
| Total Investments | $- | $324.89B | $340.04B | $320.09B | $268.89B | $282.16B | $276.78B | $247.71B | $236.27B | $240.74B | $250.47B | $242.48B | $214.73B | $208.56B | $214.45B | $217.44B | $207.32B | $206.56B | $203.63B | $202.16B |
| Total Debt | $23.06B | $3.29B | $12.02B | $11.62B | $9.84B | $9.44B | $9.55B | $9.41B | $8.66B | $6.82B | $6.65B | $6.67B | $7.08B | $7.43B | $7.75B | $7.99B | $7.42B | $7.72B | $8.03B | $8.15B |
| Net Debt | $-282.52B | $-300.12B | $-269.94B | $-346.47B | $-274.94B | $-242.93B | $-279.52B | $-299.81B | $-210.01B | $-191.23B | $-197.98B | $-247.75B | $-194.20B | $-228.63B | $-198.57B | $-268.19B | $-197.37B | $-232.71B | $-162.01B | $-200.71B |
Annual Cash Flow
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $162.03B | $220.33B | $126.27B | $143.02B | $158.52B |
| Depreciation and Amortization | $18.32B | $17.16B | $16.35B | $14.78B | $14.12B |
| Deferred Income Tax | $- | $- | $- | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- |
| Change in Working Capital | $-5.42B | $9.98B | $-38.86B | $-2.82B | $16.78B |
| Accounts Receivables | $-12.37B | $13.94B | $-43.42B | $2.99B | $21.37B |
| Inventory | $-6.34B | $-11.70B | $-7.13B | $-3.44B | $1.16B |
| Accounts Payables | $-5.82B | $7.74B | $11.69B | $-2.38B | $-5.75B |
| Other Working Capital | $19.10B | $-32.24B | $15.09B | $-16.52B | $-9.20B |
| Other Non Cash Items | $-20.65B | $-69.61B | $-1.69B | $-45.94B | $-57.47B |
| Net Cash Provided by Operating Activities | $154.28B | $177.87B | $102.07B | $109.04B | $131.94B |
| Investments in Property Plant and Equipment | $-28.27B | $-37.19B | $-31.56B | $-32.94B | $-11.77B |
| Acquisitions Net | $-27.50B | $-25.33B | $-5.38B | $-3.64B | $-8.78B |
| Purchases of Investments | $-295.96B | $-482.27B | $-399.78B | $-350.95B | $-300.46B |
| Sales Maturities of Investments | $349.39B | $467.86B | $334.20B | $385.96B | $294.16B |
| Other Investing Activities | $8.26B | $28.64B | $6.32B | $-3.70B | $-2.30B |
| Net Cash Used for Investing Activities | $5.92B | $-48.29B | $-96.20B | $-5.26B | $-29.14B |
| Debt Repayment | $- | $- | $- | $- | $- |
| Common Stock Issued | $- | $- | $- | $33.53B | $- |
| Common Stock Repurchased | $-75.18B | $-49.54B | $-14.00M | $-50.13B | $-50.16B |
| Dividends Paid | $-43.88B | $-36.14B | $-33.15B | $-32.53B | $-31.12B |
| Other Financing Activities | $-7.79B | $1.56B | $-3.46B | $5.24B | $-6.89B |
| Net Cash Used Provided by Financing Activities | $-126.85B | $-84.12B | $-36.62B | $-43.89B | $-88.17B |
| Effect of Forex Changes on Cash | $15.51B | $9.35B | $9.00B | $7.42B | $-1.56B |
| Net Change in Cash | $48.87B | $54.80B | $-21.75B | $67.31B | $13.06B |
| Cash at End of Period | $358.09B | $309.22B | $254.42B | $276.17B | $208.86B |
| Cash at Beginning of Period | $309.22B | $254.42B | $276.17B | $208.86B | $195.80B |
| Operating Cash Flow | $154.28B | $177.87B | $102.07B | $109.04B | $131.94B |
| Capital Expenditure | $-28.27B | $-37.19B | $-31.56B | $-32.94B | $-11.77B |
| Free Cash Flow | $126.02B | $140.68B | $70.50B | $76.09B | $120.17B |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $50.67B | $52.50B | $30.64B | $34.81B | $48.88B | $59.90B | $55.70B | $21.55B | $130.81B | $27.67B | $40.31B | $51.48B | $23.95B | $27.89B | $22.94B | $26.19B | $49.64B | $37.13B | $30.06B | $34.88B |
| Depreciation and Amortization | $5.44B | $5.37B | $4.92B | $4.88B | $4.57B | $4.49B | $4.38B | $4.21B | $4.30B | $4.34B | $4.30B | $4.32B | $4.18B | $4.10B | $3.75B | $3.79B | $3.74B | $3.62B | $3.63B | $3.65B |
| Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Change in Working Capital | $-13.98B | $-13.33B | $489.00M | $51.03B | $-11.54B | $-35.96B | $-11.56B | $49.65B | $-60.62B | $-2.10B | $23.05B | $-40.54B | $1.43B | $1.63B | $-1.39B | $7.75B | $-1.45B | $-4.00B | $-5.12B | $11.13B |
| Accounts Receivables | $-12.30B | $-9.05B | $633.00M | $31.94B | $-1.30B | $-38.03B | $-4.99B | $54.56B | $-65.05B | $-1.48B | $25.90B | $-42.13B | $-904.00M | $-4.06B | $3.68B | $5.82B | $-3.57B | $-4.21B | $4.95B | $- |
| Inventory | $-1.68B | $-947.00M | $-144.00M | $-588.00M | $25.00M | $-1.51B | $-4.26B | $751.00M | $-2.78B | $-3.89B | $-5.79B | $-3.94B | $-1.29B | $424.00M | $-2.32B | $3.06B | $-1.19B | $670.00M | $-5.98B | $2.54B |
| Accounts Payables | $- | $2.19B | $-8.58B | $3.19B | $-10.27B | $3.58B | $-2.31B | $-5.67B | $7.20B | $3.27B | $2.94B | $5.53B | $3.63B | $5.27B | $-2.75B | $- | $- | $- | $- | $- |
| Other Working Capital | $- | $-5.52B | $1.33B | $16.49B | $2.49B | $-10.62B | $4.93B | $-20.51B | $1.24B | $-10.10B | $-2.88B | $5.53B | $3.63B | $5.27B | $937.00M | $4.70B | $-264.00M | $-4.67B | $852.00M | $8.59B |
| Other Non Cash Items | $-1.33B | $756.00M | $-2.54B | $-28.26B | $-20.39B | $-14.27B | $-17.14B | $-13.93B | $-16.48B | $-9.79B | $-29.41B | $10.09B | $-7.86B | $1.12B | $-5.03B | $12.66B | $-40.27B | $-4.05B | $-14.28B | $-2.40B |
| Net Cash Provided by Operating Activities | $40.80B | $45.30B | $33.50B | $87.23B | $21.52B | $14.15B | $31.38B | $61.48B | $58.02B | $20.12B | $38.25B | $25.36B | $21.70B | $34.74B | $20.27B | $50.40B | $11.66B | $32.69B | $14.29B | $47.26B |
| Investments in Property Plant and Equipment | $-1.86B | $-6.16B | $-2.95B | $-6.99B | $-9.28B | $-5.68B | $-6.32B | $-2.70B | $-3.20B | $-12.95B | $-18.33B | $-10.10B | $-12.09B | $-7.38B | $-2.00B | $-18.54B | $-6.80B | $-4.32B | $-3.29B | $-905.00M |
| Acquisitions Net | $- | $-325.00M | $- | $-4.84B | $-11.05B | $-16.71B | $-3.42B | $-963.00M | $-512.00M | $-10.56B | $-13.29B | $-1.49B | $-618.00M | $-2.97B | $-300.00M | $-388.00M | $-415.00M | $-2.55B | $-3.22B | $-4.25B |
| Purchases of Investments | $- | $-86.97B | $-160.57B | $51.80B | $-99.70B | $-103.17B | $-133.77B | $-82.32B | $-88.98B | $-77.64B | $-233.32B | $-53.65B | $-134.29B | $-93.83B | $-118.00B | $-94.00B | $-108.23B | $-50.56B | $-98.14B | $-79.17B |
| Sales Maturities of Investments | $- | $75.43B | $102.72B | $-26.25B | $178.13B | $92.46B | $105.05B | $116.52B | $103.52B | $78.64B | $169.18B | $84.00B | $105.38B | $98.26B | $46.56B | $155.31B | $99.90B | $60.25B | $70.50B | $78.01B |
| Other Investing Activities | $-15.37B | $396.00M | $-87.90B | $-2.35B | $-48.00M | $-348.00M | $3.71B | $470.00M | $249.00M | $14.62B | $13.29B | $3.00B | $-1.40B | $-2.79B | $326.00M | $328.00M | $-4.16B | $2.95B | $121.00M | $-2.92B |
| Net Cash Used for Investing Activities | $-17.23B | $-17.63B | $-90.85B | $11.36B | $58.06B | $-33.46B | $-34.76B | $31.01B | $11.08B | $-7.90B | $-82.47B | $21.76B | $-41.78B | $-2.77B | $-73.41B | $42.71B | $-19.71B | $5.77B | $-34.03B | $-9.24B |
| Debt Repayment | $- | $- | $-765.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-3.00M | $-3.00M | $-3.00M | $-28.29B | $-27.43B | $-19.46B | $-2.00M | $-4.00M | $-26.18B | $-23.35B | $-1.00M | $-4.00M | $-4.00M | $-5.00M | $-1.00M | $-29.67B | $-20.46B | $-4.00M | $-2.00M | $-19.40B |
| Dividends Paid | $-24.12B | $-379.00M | $-23.97B | $-489.00M | $-22.09B | $-12.00M | $-22.29B | $-22.00M | $-18.09B | $-11.00M | $-18.09B | $-20.00M | $-16.59B | $-3.00M | $-16.58B | $-16.00M | $-16.45B | $-4.00M | $-16.10B | $-14.00M |
| Other Financing Activities | $-798.00M | $-731.00M | $-99.00M | $-5.42B | $-822.00M | $-779.00M | $-779.00M | $-508.00M | $-919.00M | $-884.00M | $3.87B | $-898.00M | $-813.00M | $-865.00M | $-879.00M | $-899.00M | $9.51B | $-890.00M | $-2.48B | $-947.00M |
| Net Cash Used Provided by Financing Activities | $-24.92B | $-1.11B | $-24.83B | $-28.50B | $-50.34B | $-20.22B | $-23.07B | $-490.00M | $-45.19B | $-24.23B | $-14.22B | $-882.00M | $-17.41B | $-867.00M | $-17.46B | $-30.55B | $-27.40B | $32.64B | $-18.58B | $-20.33B |
| Effect of Forex Changes on Cash | $3.53B | $-5.11B | $6.05B | $3.21B | $3.18B | $2.83B | $6.30B | $-1.44B | $-3.28B | $5.42B | $8.65B | $6.90B | $2.71B | $-1.36B | $750.00M | $8.82B | $-196.00M | $-710.00M | $-490.00M | $-947.00M |
| Net Change in Cash | $305.58B | $21.45B | $-76.13B | $73.30B | $32.42B | $-36.70B | $-20.15B | $90.56B | $20.63B | $-6.59B | $-49.79B | $53.14B | $-34.78B | $29.74B | $-69.85B | $71.39B | $-35.65B | $70.40B | $-38.82B | $16.74B |
| Cash at End of Period | $305.58B | $303.40B | $281.96B | $358.09B | $284.79B | $252.37B | $289.08B | $309.22B | $218.67B | $198.04B | $204.63B | $254.42B | $201.28B | $236.06B | $206.32B | $276.17B | $204.79B | $240.44B | $170.04B | $208.86B |
| Cash at Beginning of Period | $- | $281.96B | $358.09B | $284.79B | $252.37B | $289.08B | $309.22B | $218.67B | $198.04B | $204.63B | $254.42B | $201.28B | $236.06B | $206.32B | $276.17B | $204.79B | $240.44B | $170.04B | $208.86B | $192.12B |
| Operating Cash Flow | $40.80B | $45.30B | $33.50B | $87.23B | $21.52B | $14.15B | $31.38B | $61.48B | $58.02B | $20.12B | $38.25B | $25.36B | $21.70B | $34.74B | $20.27B | $50.40B | $11.66B | $32.69B | $14.29B | $47.26B |
| Capital Expenditure | $-1.86B | $-5.12B | $-2.95B | $-6.99B | $-9.28B | $-5.68B | $-6.32B | $-2.70B | $-3.20B | $-12.95B | $-18.33B | $-10.10B | $-12.09B | $-7.38B | $-2.00B | $-18.54B | $-6.80B | $-4.32B | $-3.29B | $-905.00M |
| Free Cash Flow | $38.94B | $40.18B | $30.55B | $80.24B | $12.25B | $8.47B | $25.06B | $58.78B | $54.81B | $7.17B | $19.92B | $15.26B | $9.61B | $27.36B | $18.27B | $31.86B | $4.86B | $28.38B | $11.00B | $46.35B |
Shionogi & Dividends
Explore Shionogi & 's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
1.99%
Dividend Payout Ratio
27.08%
Dividend Paid & Capex Coverage Ratio
2.14x
Shionogi & Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $29 | $29 | March 28, 2025 | March 31, 2025 | June 01, 2025 | |
| $85 | $28.330499999999997 | September 27, 2024 | September 30, 2024 | December 02, 2024 | |
| $85 | $28.330499999999997 | March 28, 2024 | |||
| $75 | $24.9975 | September 28, 2023 | September 30, 2023 | December 01, 2023 | |
| $75 | $24.9975 | March 30, 2023 | March 31, 2023 | June 22, 2023 | |
| $60 | $19.997999999999998 | September 29, 2022 | September 30, 2022 | December 01, 2022 | |
| $180 | $60 | March 30, 2022 | March 31, 2022 | June 24, 2022 | |
| $165 | $55 | September 29, 2021 | September 30, 2021 | December 01, 2021 | |
| $53 | $17.66667 | March 30, 2021 | March 31, 2021 | June 23, 2021 | |
| $159 | $53 | September 29, 2020 | September 30, 2020 | December 01, 2020 | |
| $159 | $53 | March 30, 2020 | March 31, 2020 | June 24, 2020 | |
| $150 | $50 | September 27, 2019 | September 30, 2019 | December 02, 2019 | |
| $50 | $16.66667 | March 27, 2019 | March 31, 2019 | June 19, 2019 | |
| $132 | $44 | September 26, 2018 | September 30, 2018 | December 03, 2018 | |
| $132 | $44 | March 28, 2018 | March 31, 2018 | June 21, 2018 | |
| $38 | $12.66667 | September 27, 2017 | September 30, 2017 | December 01, 2017 | |
| $114 | $38 | March 29, 2017 | March 31, 2017 | June 23, 2017 | |
| $34 | $11.33333 | September 28, 2016 | |||
| $102 | $34 | March 29, 2016 | |||
| $84 | $28 | September 28, 2015 |
Shionogi & News
Read the latest news about Shionogi & , including recent articles, headlines, and updates.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for 4507.T.